Amazon.com, Inc. (AMZN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN)

AMZN 233.22

+1.8%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Skeeter Bug who wrote (121482)	3/24/2001 12:23:40 PM
From: 16yearcycle	Read Replies (2) of 164684

Message 15553925 Skeeter, you are starting to scare me. How strong of a nibble? I don't believe for a moment that they really thought that Enbrel could be effective for heart failure, which has almost nothing to do with autoimmunity. And it is a med for rheumatoid arthritis, which "everyone" is not going to have. (You are thinking about degenerative joint disease or osteoarthritis. Rheumatoid is an inflammatory arthritis caused by an autoimmune component. DJD is caused by injury, and normal wear and tear.) Still, Enbrel is the only new rheumatoid drug out in ages. They are nearly in a monopolistic situation with this med, and I do think it can be used for psoriasis in addition to psoriatic arthritis. I would say there is some very solid possibility that it can be used in other autoimmune disorders, but that is the speculative part. Enbrel is a miracle drug for those who tolerate it well, but it has been toxic in some cases. The other meds commonly used are much more dangerous, and not as effective. This is THE first chance I can recall to buy a biotech with real profits and a real franchise for 3x over cash in the bank.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next